Holen Sie sich die Stockscreener-App
4.555
0.33%
0.015
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Deeper Dive: Understanding Olema Pharmaceuticals Inc (OLMA) Through its Various Ratios - DWinneX
Olema Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Two Sigma Investments LP Has $425,000 Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Squarepoint Ops LLC Grows Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
HC Wainwright Issues Pessimistic Outlook for OLMA Earnings - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Acquired by Wellington Management Group LLP - MarketBeat
Jane Street Group LLC Trims Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Q2 EPS Forecast for Olema Pharmaceuticals Lowered by Analyst - Defense World
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Two Sigma Advisers LP - Defense World
ProShare Advisors LLC Purchases 3,298 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Ru - GuruFocus
Olema Oncology Expands Team with 322,000 Share Options Grant to New Biotech Talent - Stock Titan
Deutsche Bank AG Increases Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Bank of America Corp DE Has $5.05 Million Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Millennium Management LLC Acquires 901,159 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance - MSN
H.C. Wainwright maintains Buy on Olema Pharma, $28 target By Investing.com - Investing.com UK
D. E. Shaw & Co. Inc. Cuts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Ameriprise Financial Inc. Has $2.62 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Pharmaceuticals, Inc. Announces Palazestrant Dose Selection and Trial-In-Progress Poster at ASCO 2025 Annual Meeting - marketscreener.com
Olema Pharmaceuticals (OLMA) Aligns with FDA on Key Dosage for Trials | OLMA Stock News - GuruFocus
Olema Oncology Announces Palazestrant Dose Selection and Trial-in-Progress Poster at ASCO 2025 Annual Meeting - GlobeNewswire
FDA Green Lights Crucial Dose for Olema's Advanced Breast Cancer Drug with 2027 Launch Target - Stock Titan
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Millennium Management LLC - Defense World
Bank of America Corp DE Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Northern Trust Corp Buys 34,053 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
BNP Paribas Financial Markets Makes New $1.13 Million Investment in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Olema Oncology to Participate in Upcoming Investor Conferences - The Manila Times
Olema Oncology Advances Cancer Trials with Strong Financials - TipRanks
Olema Oncology to Participate in Upcoming Investor Conferences | - GuruFocus
Olema Oncology to Participate in Upcoming Investor Conferences | OLMA Stock News - GuruFocus
Breast Cancer Biotech Olema Sets Major Presentations at Goldman Sachs and Jefferies Healthcare Conferences - Stock Titan
Paradigm Biocapital Advisors LP Purchases 1,801,370 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Bought by MPM Bioimpact LLC - MarketBeat
Price T Rowe Associates Inc. MD Has $153,000 Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
The Goldman Sachs Group Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $18.00 - Defense World
Oppenheimer Cuts Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $22.00 - Defense World
Q2 EPS Estimate for Olema Pharmaceuticals Raised by Analyst - Defense World
Voya Investment Management LLC Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Driehaus Capital Management LLC Invests $1.28 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Analysts Offer Insights on Healthcare Companies: Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST) and Olema Pharmaceuticals (OLMA) - The Globe and Mail
Companies Like Olema Pharmaceuticals (NASDAQ:OLMA) Are In A Position To Invest In Growth - Yahoo Finance
Olema Pharmaceuticals (OLMA) Price Target Lowered by Oppenheimer - GuruFocus
Balyasny Asset Management L.P. Increases Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (OLMA) Price Target Lowered by Goldman Sachs | OLMA Stock News - GuruFocus
1.62%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):